Get the Stockscreener App
6.73
8.97%
-0.68
Meiragtx Holdings Plc stock is traded at $6.73, with a volume of 535.62K.
It is down -8.97% in the last 24 hours and down -6.32% over the past month.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
See More
Previous Close:
$7.41
Open:
$7.26
24h Volume:
535.62K
Relative Volume:
1.30
Market Cap:
$541.70M
Revenue:
$14.02M
Net Income/Loss:
$-84.03M
P/E Ratio:
-4.5782
EPS:
-1.47
Net Cash Flow:
$-125.54M
1W Performance:
-11.95%
1M Performance:
-6.32%
6M Performance:
-12.29%
1Y Performance:
+2.51%
1-Day Range:
$6.71
$7.30
1-Week Range:
$6.71
$7.935
52-Week Range:
$4.55
$9.73
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
6.73 | 596.44M | 14.02M | -84.03M | -125.54M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.05 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.80 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.82 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
290.39 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday - MarketBeat
MGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How Meiragtx Holdings Plc (MGTX) Affects Rotational Strategy Timing - Stock Traders Daily
Revenue per share of MeiraGTx Holdings Plc – FWB:328 - TradingView
Aug Weekly: Does MeiraGTx Holdings plc have consistent dividend growthAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 249% Upside - DirectorsTalk Interviews
MGTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is MeiraGTx Holdings plc gaining market share2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4 - Stock Titan
MeiraGTx (MGTX) CEO vests 62,500 RSUs, withholds shares for taxes - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 254.77% Potential Upside in Gene Therapy Innovations - DirectorsTalk Interviews
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
(MGTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors - MSN
MGTX Should I Buy - Intellectia AI
MeiraGTx (NASDAQ:MGTX) Trading Up 1.7%Should You Buy? - MarketBeat
Is MeiraGTx Holdings plc’s ROIC above industry averageJuly 2025 Levels & Safe Swing Trade Setups - mfd.ru
Resistance Check: Is MeiraGTx Holdings plc stock a good dividend stockPortfolio Performance Summary & Fast Gain Swing Trade Alerts - mfd.ru
Why MeiraGTx Holdings plc stock attracts high net worth investorsWeekly Stock Summary & Weekly Watchlist for Consistent Profits - mfd.ru
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 263% Upside - DirectorsTalk Interviews
What is MeiraGTx Holdings plc s debt to equity ratioTrade Performance Summary & High Conviction Buy Zone Picks - mfd.ru
Risk Check: Should I invest in MeiraGTx Holdings plc before earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Responsive Playbooks and the MGTX Inflection - Stock Traders Daily
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio - Ophthalmology Times
Meiragtx licenses Zipbio’s gene therapies for geographic atrophy - bioworld.com
Retail Surge: Can MeiraGTx Holdings plc stock outperform in a bear marketWeekly Trading Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Resistance Check: Is Smith Micro Software Inc. gaining market shareTrade Analysis Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy By Investing.com - Investing.com Australia
ZipBio and MeiraGTx Enter Into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - 富途牛牛
MeiraGTx Signs Exclusive License Deal for ZipBio's Geographic Atrophy Therapies - marketscreener.com
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - Investing News Network
MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy - Investing.com Nigeria
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy - Investing.com
Winners Losers: What is the earnings history of MeiraGTx Holdings plcQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
What’s the outlook for MeiraGTx Holdings plc’s sectorInsider Selling & Long-Term Growth Plans - mfd.ru
Retail Surge: What is the earnings history of MeiraGTx Holdings plcTrade Ideas & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Analyst Upgrade: What is the earnings history of MeiraGTx Holdings plcPortfolio Return Report & Low Risk High Reward Ideas - baoquankhu1.vn
Is MeiraGTx Holdings plc likely to announce a buybackJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - mfd.ru
Understanding the Setup: (MGTX) and Scalable Risk - Stock Traders Daily
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Short Covering: Can MeiraGTx Holdings plc stock outperform in a bear marketFed Meeting & Free Verified High Yield Trade Plans - baoquankhu1.vn
AMH Equity Ltd Invests $658,000 in MeiraGTx Holdings PLC $MGTX - Defense World
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - MSN
The Technical Signals Behind (MGTX) That Institutions Follow - Stock Traders Daily
MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with a 247.85% Upside Potential - DirectorsTalk Interviews
Should I invest in MeiraGTx Holdings plc before earningsJobs Report & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):